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Summary
In a clinical trial where cattle were 
either given Excede® or not on arrival, 
ADG increased and F:G was numeri-
cally improved for cattle that received 
Excede compared to control cattle. There 
were no differences between initial or 
final BW, or DMI observed during the 
receiving period due to the administra-
tion of Excede. The incidence of bovine 
respiratory disease (BRD) for the 32 
days of the study was 4.4% for cattle 
that received Excede at arrival and 
was different compared to the control 
cattle which was 12.2%. The correlation 
(-0.157) between DMI and morbid-
ity observed in this study was not sig-
nificant. Metaphylactic treatment with 
Excede improved ADG and effectively 
reduced the cumulative incidence of 
BRD during the study. 
Introduction
Controlling BRD among incoming 
calves using metaphylaxis (mass med-
ication of cattle with antibiotics at 
feedyard arrival) may be an important 
management option for veterinarians 
and cattle producers. A previous study 
evaluated the effect of administra-
tion of a long-acting formulation of 
ceftiofur crystalline free acid (Excede® 
Sterile Suspension, Pfizer Animal 
Health, New York, N.Y.) at arrival, or 
at revaccination (16 to 27 days after 
arrival) on morbidity, mortality, and 
BW gain of calves (2007 Nebraska Beef 
Report, pp. 68-70). In this study, calf 
morbidity from BRD was predomi-
nantly within the first 10 to 14 days. 
Excede administered at arrival sig-
nificantly reduced (P<0.01) the inci-
dence of BRD compared to treatment 
at revaccination. A -0.22 correlation 
(P < 0.01) was observed between the 
proportions of steers pulled for BRD 
treatment and daily DM offered. 
However, DMI was restricted initially 
with ad libitum intakes after day 10.
The objective of the current study 
was to determine the effect of admin-
istering Excede at feedlot arrival on 
morbidity, mortality, BW gain, and 
the correlation of DMI to pen mor-
bidity rates during the first 0 to 5 
days of the feedlot receiving period.
Procedure
Two treatments were evaluated 
within the feedlot receiving system: 1) 
control (no arrival treatment) with no 
post treatment interval (PTI) observed 
(CONTROL), or 2) Excede® Sterile 
Suspension on arrival using the base 
of the ear as the injection site with a 
PTI of 7 days observed (EXCEDE). A 
total of 842 steer calves received at the 
University of Nebraska Agricultural 
Research and Development Center 
between Oct. 17 and Oct. 29, 2006, 
were used in this experiment. Steers 
were a mixture of “ranch-direct” and 
“auction market” sources. Steers were 
housed by treatment group and pens 
sharing a water tank were assigned 
to the same treatment in order to 
minimize environmental cross-expo-
sure, or cross-protection. Fifty-two 
feedlot pens housed between 12 and 
20 head/pen to supply 26 replications 
per treatment. Pens were blocked by 
arrival day (6 blocks). Steers received 
ad libitum intake of a typical feedlot 
receiving diet containing (DM basis) 
27% dry rolled corn, 5% alfalfa hay, 
5% wet corn gluten feed, and % 
supplement containing 15 mg/steer 
daily Deccox® (Alpharma Inc., Fort 
Lee, N.J.) and 200 mg/steer daily 
Rumensin (Elanco Animal Health, 
Greenfield, Ind.). Steers also received 
long-stem grass hay (.4 lb/head/day, 
DM basis), which was removed after 
day 2.
Steers were assigned to treatment 
based on processing order on arrival, 
with every other animal assigned to 
each treatment. Only calves that were 
large framed and weighed more than 
550 lb were assigned on this experi-
ment as all of these calves were des-
ignated as “calf-feds.” Steers’ ID tags 
were notched to identify treatment 
assignment. Calves were processed on 
arrival by receiving three separate tags 
for individual identification including 
an electronic ID, panel tag, and metal 
clip tag. Calves were weighed and vac-
cinated with the following at feedlot 
arrival: BoviShield™ Gold 5, Somu-
bac®, and Dectomax® Injectable (Pfizer 
Animal Health). All calves with horns 
were dehorned or tipped as needed. 
Intact bull calves were excluded from 
this study. Calves were weighed and 
revaccinated at 10-14 days after arrival 
which included vaccination with So-
mubac/Ultrabac® 7 and a second dose 
of BoviShield Gold 5. Calves were indi-
vidually weighed off trial after 2 days 
(range 0-5 days) following a 5-day 
limit-fed period to minimize variation 
due to gut fill.
All pens were evaluated by the 
same animal health personnel within 
the same day to provide equivalent 
evaluation across treatments. Calves 
categorized as sick by the cattle crew 
were pulled, symptoms assessed, rec-
tal temperature recorded, and BRD 
cases treated with Draxxin® Injectable 
Solution (Pfizer Animal Health, New 
York, N.Y.). When sick calves were 
treated, their panel ID tag was marked 
to prevent retreating. Animals were 
returned to home pens as soon as pos-
sible after treatment. A PTI of 7 days 
was honored after treatment with 
Draxxin before another treatment 
could occur. Any animals that were 
pulled for reasons other than respira-
tory disease were treated according to 
UNL feedlot SOPs.
(Continued on next page)
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Initial BW, revaccination BW, final 
BW, ADG, DMI, feed:gain ratio, mor-
bidity and mortality were measured. 
Initial BW was based on BW recorded 
at arrival and was assumed to be a 
shrunk weight. Final BW was based 
on the average of 2-day consecutive 
weights recorded at the end of the trial 
after a 5-day limit-feeding period to 
minimize variation due to gut fill. 
Body weight, ADG, DMI, F:G, and pull 
rate data using pen as the experimen-
tal unit were analyzed using the Proc 
MIXED procedure of SAS (Version 
9.1, SAS Inc., Cary, N.C.) with arrival 
(and source) as a blocking criteria 
and antibiotic treatment as a fixed 
effect. The Proc CORR procedure of 
SAS (Version 9.1, SAS Inc.) was used 
to correlate DMI and morbidity. The 
Proc GENMOD procedure of SAS 
(Version 9.1, SAS Inc.) was used to 
analyze binary respiratory disease 
morbidity outcomes in a generalized 
estimating equations model using 
the logit link and accounting for cor-
relation of animals within pen. An 
animal was classified as a respiratory 
disease observation for the trial if the 
animal was treated for respiratory dis-
ease by the animal health personnel.
Results
There were no significant differ-
ences (P > 0.05) between initial BW 
(612 ± 4 lb), revaccination BW (661 
± 5 lb), final BW (687 ± 5 lb), or DMI 
(1.9 lb/day) observed in this study 
due to administration of Excede 
(Table 1). ADG over the study period 
was 8% higher for cattle that received 
Excede on arrival than for those that 
did not. Cattle that received Excede 
on arrival had a greater (P = 0.02) 
ADG and a numerically improved  
(P = 0.07) F:G ratio compared with 
CONTROL cattle. A total of 71 
animals were treated for BRD in this 
study, 19 from EXCEDE and 52 in 
CONTROL. Also, there were not any 
animals in this study that had to be 
retreated or that died. With treated 
animals removed from the dataset, 
EXCEDE cattle continued to have sig-
nificantly greater (P < 0.01) ADG and 
significantly improved (P = 0.02) F:G 
Table 1. Effects of administration of Excede at arrival on performance during the 32-day receiving 
period.
 CONTROL EXCEDE SEM P-Value
Results for All Animals Using Pen as the Experimental Unit
Initial BW, lb 614 610 4 0.2
Revac BW, lba 659 66 5 0.51
Final BW, lb 686 687 5 0.75
DMI, lb/day 1.7 14.0 0.2 0.1
ADG, lb 2.20 2.7 0.07 0.02
F:Gb 6.21 5.88  0.07
Results Excluding 71 Animals Treated for BRD
Initial BW, lb 615 610 4 0.22
Revac BW, lba 660 66 5 0.58
Final BW, lb 686 688 5 0.77
DMI, lb/day 1.7 14.0 0.2 0.1
ADG, lb 2.19 2.40 0.08 <0.01
F:Gb 6.25 5.81  0.02
aRevac BW = Revaccination BW.
bAnalyzed as gain:feed, reciprocal of feed conversion.
Figure 1. Incidence density of first pulls for BRD by treatment and days on trial.
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Figure 2. Cumulative incidence of BRD for the study period by treatment. 
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ratio compared to CONTROL cattle. 
There were no differences observed for 
BW or DMI. The correlation (-0.157) 
between DMI and pen-level incidence 
of BRD morbidity for the study period 
was not significant (P = 0.27).
CONTROL and EXCEDE cattle 
were first pulled for BRD at different 
periods of time after receiving (Figure 
1). CONTROL cattle had a higher 
incidence of BRD at the beginning of 
the study, mainly between day 0 and 
day 10; however, EXCEDE cattle were 
not eligible for BRD treatment until 8 
days after enrollment into the study. 
The incidence of BRD for cattle treat-
ed with Excede peaked between days 
21-25. The only variable that signifi-
cantly explained the incidence of BRD 
was metaphylactic treatment with 
Excede (odds ratio = 0., P < 0.01). 
Cumulative incidence of BRD for the 
study period was 4.4% for cattle that 
received Excede at arrival and 12.5% 
for CONTROL cattle. Cattle that re-
ceived metaphylactic treatment were 
64% less likely to be treated for BRD 
than CONTROL cattle.
In conclusion, metaphylatic treat-
ment with Excede at arrival in the 
feedlot effectively reduced the inci-
dence of BRD by 64%, and also im-
proved ADG 8% during the receiving 
period compared to no metaphylaxis.
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